Literature DB >> 16695779

FURTHER STUDIES WITH THE SALT TOLERANCE TEST IN NORMAL INDIVIDUALS AND IN PATIENTS WITH ADRENAL CORTICAL HYPERFUNCTION.

L J Soffer1, J L Gabrilove, M D Jacobs.   

Abstract

Entities:  

Keywords:  ADRENALS/diseases

Mesh:

Year:  1949        PMID: 16695779      PMCID: PMC439664          DOI: 10.1172/JCI102141

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  1 in total

1.  THE UTILIZATION OF INTRAVENOUSLY INJECTED SALT IN NORMALS AND IN PATIENTS WITH CUSHING'S SYNDROME BEFORE AND AFTER ADMINISTRATION OF DESOXYCORTICOSTERONE ACETATE.

Authors:  L J Soffer; G Lesnick; S Z Sorkin; H H Sobotka; M Jacobs
Journal:  J Clin Invest       Date:  1944-01       Impact factor: 14.808

  1 in total
  7 in total

1.  ADRENO-CORTICAL HYPERACTIVITY--TWO INTERESTING CASES.

Authors:  R W LOGAN; N L MCMILLAN
Journal:  Postgrad Med J       Date:  1964-10       Impact factor: 2.401

2.  Response of normal subjects to large amounts of aldosterone.

Authors:  J T AUGUST; D H NELSON; G W THORN
Journal:  J Clin Invest       Date:  1958-11       Impact factor: 14.808

3.  The role of adrenal steroids on renal function and electrolyte metabolism.

Authors:  L J SOFFER; A GUTMAN; J GELLER; J L GABRILOVE
Journal:  Bull N Y Acad Med       Date:  1957-10

4.  Diagnosis of endocrine disease: clinical and laboratory considerations.

Authors:  L J SOFFER
Journal:  Bull N Y Acad Med       Date:  1953-02

5.  Techniques for the Evaluation of Adrenal Cortical Function by the Use of Adrenocorticotrophin: A Review.

Authors:  F T Prunty
Journal:  J Clin Pathol       Date:  1950-05       Impact factor: 3.411

6.  The Soffer test in essential hypertension.

Authors:  F LONDON; L L TERRY
Journal:  J Clin Invest       Date:  1952-01       Impact factor: 14.808

7.  Compartmental distribution of sodium chloride in surgical patients pre- and post-operatively.

Authors:  I M ARIEL; A J KREMEN
Journal:  Ann Surg       Date:  1950-12       Impact factor: 12.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.